Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Merck Serono and Ono Pharmaceutical collaborate on MS drug and cancer vaccine

Oct. 5, 2011

Intellect Neurosciences and ViroPharma enter licensing agreement for OX-1

Oct. 5, 2011

MedImmune in-licenses tremelimumab from Pfizer

Oct. 4, 2011

Children's Oncology Group and Apeiron to collaborate on phase II study in neuroblastoma

Oct. 3, 2011

NanoCarrier and Kowa to enter worldwide agreement for NC-6300

Sep. 30, 2011

JDRF and iCo Therapeutics partner to support phase II iCo-007 study

Sep. 30, 2011

Vaxent and PREVENT to collaborate on group A Streptococcus vaccine

Sep. 30, 2011

NIH selects Afraxis for TRND program on PAK biology

Sep. 29, 2011

Riemser Arzneimittel receives German license for CINV combination therapy

Sep. 29, 2011

Photocure and Ipsen to commercialize Hexvix

Sep. 28, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...